BioCardia, Inc.
BCDA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000925741
In the last 90 days, BioCardia, Inc. insiders filed 10 open-market purchases and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.65M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding BioCardia, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 24 | 22 | −2 |
| Shares | 2.06M | 1.95M | −112.0K (−5.4%) |
| Value | $1.37M | $790.8K | −$574.4K (−42.1%) |
New holders (3)
Institutions that held BioCardia, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Securities, LLC | 111,079 | $45.2K | 0.00% |
| Octavia Wealth Advisors, LLC | 14,238 | $5.79K | 0.00% |
| Simplex Trading, LLC | 7,207 | $2.00K | 0.00% |
Sold out (5)
Institutions that held BioCardia, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Renaissance Technologies LLC | 88,300 | $59.0K |
| Susquehanna International Group, LLP | 65,426 | $43.5K |
| Citadel Advisors LLC | 33,629 | $22.3K |
| Scientech Research LLC | 23,032 | $14.9K |
| HRT Financial LP | 18,335 | $12.0K |